{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:57:59Z","timestamp":1788195479408,"version":"build-2803163510"},"reference-count":128,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.rdc.2007.11.006","type":"journal-article","created":{"date-parts":[[2008,3,12]],"date-time":"2008-03-12T14:37:26Z","timestamp":1205332646000},"page":"89-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Diagnosis and Management of Scleroderma Peripheral Vascular Disease"],"prefix":"10.1016","volume":"34","author":[{"given":"Ariane","family":"Herrick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rdc.2007.11.006_bib1","first-page":"485","article-title":"Raynaud's phenomenon: a proposal for classification","volume":"10","author":"LeRoy","year":"1992","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","author":"Masi","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2007.11.006_bib3","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/rheumatology\/keh552","article-title":"Pathogenesis of Raynaud's phenomenon","volume":"44","author":"Herrick","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2007.11.006_bib4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0049-0172(75)90017-7","article-title":"Pathogenesis of systemic sclerosis: a vascular hypothesis","volume":"4","author":"Campbell","year":"1975","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2007.11.006_bib5","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0889-857X(05)70295-7","article-title":"Systemic sclerosis. A vascular perspective","volume":"22","author":"LeRoy","year":"1996","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.rdc.2007.11.006_bib6","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00002281-200011000-00009","article-title":"Vascular function in systemic sclerosis","volume":"12","author":"Herrick","year":"2000","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00005792-198011000-00001","article-title":"Morphological changes in the digital arteries of patients with progressive systemic sclerosis (scleroderma) and Raynaud phenomenon","volume":"59","author":"Rodnan","year":"1980","journal-title":"Medicine"},{"key":"10.1016\/j.rdc.2007.11.006_bib8","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/ard.54.10.853","article-title":"Increased prevalence of symptomatic macrovascular disease in systemic sclerosis","volume":"54","author":"Veale","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2007.11.006_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/ard.59.1.39","article-title":"Macrovascular disease and systemic sclerosis","volume":"59","author":"Ho","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2007.11.006_bib10","first-page":"469","article-title":"Limited scleroderma is associated with increased prevalence of macrovascular disease","volume":"22","author":"Youseff","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib11","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/rheumatology\/40.10.1102","article-title":"Ankle brachial pressure index in systemic sclerosis: influence of disease subtype and anticentromere antibody","volume":"40","author":"Wan","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2007.11.006_bib12","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/rheumatology\/kel433","article-title":"Angiotensin-converting enzyme I\/D polymorphism and macrovascular disease in systemic sclerosis","volume":"46","author":"Bartoli","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2007.11.006_bib13","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1365-2133.2006.07475.x","article-title":"Arteriographic evaluation of vascular changes of the extremities in patients with systemic sclerosis","volume":"155","author":"Hasegawa","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib14","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/archinte.1972.03650050036006","article-title":"Digital arteries in patients with scleroderma: arteriographic and plethysmographic study","volume":"130","author":"Dabich","year":"1972","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.rdc.2007.11.006_bib15","first-page":"262","article-title":"Arteries of the hand in patients with scleroderma","volume":"55","author":"Janevski","year":"1986","journal-title":"Diagn Imaging Clin Med"},{"key":"10.1016\/j.rdc.2007.11.006_bib16","first-page":"295","article-title":"Macroangiopathy of the upper extremities in progressive systemic sclerosis","volume":"5","author":"Stucker","year":"2000","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.rdc.2007.11.006_bib17","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/ard.57.8.476","article-title":"Distribution of macrovascular disease in scleroderma","volume":"57","author":"Stafford","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2007.11.006_bib18","first-page":"102","article-title":"Ulnar artery involvement in systemic sclerosis (scleroderma)","volume":"29","author":"Taylor","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib19","first-page":"942","article-title":"Vasculitis in systemic sclerosis: association with Sj\u00f6gren's syndrome and the CREST syndrome","volume":"14","author":"Oddis","year":"1987","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib20","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/rheumatology\/38.5.479","article-title":"Giant cell arteritis in a patient with limited cutaneous systemic sclerosis","volume":"38","author":"Sari-Kouzel","year":"1999","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2007.11.006_bib21","first-page":"685","article-title":"Large vessel arterial thrombosis in systemic sclerosis associated with antiphospholipid antibodies","volume":"17","author":"Shapiro","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib22","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/rheumatology\/32.5.357","article-title":"Validity and reliability of three methods used in the diagnosis of Raynaud's phenomenon","volume":"32","author":"Brennan","year":"1993","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib23","first-page":"454","article-title":"Diagnosis of Raynaud's phenomenon assisted by color charts","volume":"15","author":"Maricq","year":"1988","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib24","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0002-9343(82)90846-4","article-title":"A prospective study of Raynaud phenomenon and early connective tissue disease","volume":"72","author":"Harper","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/j.rdc.2007.11.006_bib25","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/archinte.158.6.595","article-title":"Outcomes in primary Raynaud phenomenon. A meta-analysis of the frequency, rates, and predictors of transition to secondary diseases","volume":"158","author":"Spencer-Green","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.rdc.2007.11.006_bib26","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1056\/NEJMcp064483","article-title":"Intermittent claudication","volume":"356","author":"White","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2007.11.006_bib27","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/art.1780350614","article-title":"Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis","volume":"35","author":"Wigley","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2007.11.006_bib28","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/ard.53.8.540","article-title":"Anticardiolipin, anticentromere and anti-Scl-70 antibodies in patients with systemic sclerosis and severe digital ischaemia","volume":"53","author":"Herrick","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2007.11.006_bib29","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/art.10486","article-title":"Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon","volume":"46","author":"Merkel","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2007.11.006_bib30","first-page":"2159","article-title":"A disease severity scale for systemic sclerosis: development and testing","volume":"26","author":"Medsger","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib31","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/ard.57.2.70","article-title":"Quantifying digital vascular disease in patients with primary Raynaud's phenomenon and systemic sclerosis","volume":"57","author":"Herrick","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2007.11.006_bib32","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1080\/00365517809104885","article-title":"Raynaud phenomenon and finger systolic pressure during cooling","volume":"38","author":"Neilson","year":"1978","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.rdc.2007.11.006_bib33","first-page":"2068","article-title":"Digital vascular responses to cooling in subjects with cold sensitivity, primary Raynaud's phenomenon, or scleroderma-spectrum disorders","volume":"23","author":"Maricq","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib34","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/art.1780240907","article-title":"Widefield capillary microscopy. Technique and rating scale for abnormalities seen in scleroderma and related disorders","volume":"24","author":"Maricq","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2007.11.006_bib35","first-page":"556","article-title":"Diagnostic significance of nailfold capillary patterns in patients with Raynaud's phenomenon","volume":"13","author":"Houtman","year":"1986","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib36","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/ard.60.4.407","article-title":"Differentiation between primary and secondary Raynaud's phenomenon: a prospective study comparing nailfold capillaroscopy using an opthalmoscope or stereomicroscope","volume":"60","author":"Anders","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2007.11.006_bib37","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/archderm.139.8.1027","article-title":"The handheld dermatoscope as a nail-fold capillaroscopic instrument","volume":"139","author":"Bergman","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib38","first-page":"289","article-title":"Early detection of scleroderma-spectrum disorders by in vivo capillary microscopy","volume":"9","author":"Maricq","year":"1982","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib39","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1002\/art.11310","article-title":"Raynaud's phenomenon and the role of capillaroscopy","volume":"11","author":"Cutolo","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2007.11.006_bib40","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0889-857X(21)01041-3","article-title":"Microvasculature in systemic sclerosis","volume":"16","author":"Carpentier","year":"1990","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.rdc.2007.11.006_bib41","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2340\/0001555566139143","article-title":"Quantification of the nail fold capillary abnormalities in systemic sclerosis and Raynaud's syndrome","volume":"66","author":"Statham","year":"1986","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1016\/j.rdc.2007.11.006_bib42","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/rheumatology\/35.11.1127","article-title":"Increased nailfold capillary dimensions in primary Raynaud's phenomenon and systemic sclerosis","volume":"35","author":"Bukhari","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib43","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/art.1780160506","article-title":"Patterns of finger capillary abnormalities in connective tissue disease by \u2018wide-field\u2019 microscopy","volume":"16","author":"Maricq","year":"1973","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2007.11.006_bib44","first-page":"930","article-title":"Nailfold capillary microscopy in the connective tissue diseases: a semiquantitative assessment","volume":"10","author":"Lee","year":"1983","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib45","first-page":"564","article-title":"Digital blood flow and nailfold capillary microscopy in Raynaud's phenomenon","volume":"13","author":"Lee","year":"1986","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib46","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/ard.45.9.741","article-title":"Nailfold capillary microscopy in connective tissue disease: a quantitative morphological analysis","volume":"45","author":"Lefford","year":"1986","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2007.11.006_bib47","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0049-0172(94)90098-1","article-title":"Serial nailfold capillary microscopy in primary Raynaud's phenomenon and scleroderma","volume":"24","author":"Ter Borg","year":"1994","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2007.11.006_bib48","first-page":"35","article-title":"Digitized nailfold capillaroscopy","volume":"23","author":"Michoud","year":"1994","journal-title":"Vasa"},{"key":"10.1016\/j.rdc.2007.11.006_bib49","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/ard.55.8.507","article-title":"Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls","volume":"55","author":"Kabasakal","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2007.11.006_bib50","first-page":"219","article-title":"Capillary density in patients with systemic sclerosis, as determined by microscopy counts and compared with computer-based analysis","volume":"17","author":"Wildt","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib51","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1468-3083.2004.00853.x","article-title":"Nailfold digital capillaroscopy in 447 patients with connective tissue disease and Raynaud's disease","volume":"18","author":"Nagy","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.rdc.2007.11.006_bib52","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/rheumatology\/39.5.506","article-title":"Quantitation of microcirculatory abnormalities in patients with primary Raynaud's phenomenon and systemic sclerosis by video capillaroscopy","volume":"39","author":"Bukhari","year":"2000","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2007.11.006_bib53","first-page":"841","article-title":"Computerized nailfold video capillaroscopy\u2014a new tool for the assessment of Raynaud's phenomenon","volume":"32","author":"Anderson","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib54","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/rheumatology\/keh156","article-title":"Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis","volume":"43","author":"Cutolo","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2007.11.006_bib55","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/rheumatology\/kel383","article-title":"Assessment of digital vascular structure and function in response to bosentan in patients with systemic sclerosis-related Raynaud's phenomenon","volume":"46","author":"Moore","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2007.11.006_bib56","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/rheumatology\/40.12.1384","article-title":"The use of portable radiometry to access Raynaud's phenomenon: a practical alternative to thermal imaging","volume":"40","author":"Cherkas","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2007.11.006_bib57","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/ard.44.2.73","article-title":"Prostaglandin E1 vasospastic disease and thermography","volume":"44","author":"Kyle","year":"1985","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2007.11.006_bib58","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/rheumatology\/30.3.190","article-title":"Pyroelectric vidicon thermography and cold challenge quantify the severity of Raynaud's phenomenon","volume":"30","author":"Darton","year":"1991","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib59","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1136\/ard.51.11.1193","article-title":"Measurement of cold challenge responses in primary Raynaud's phenomenon and Raynaud's phenomenon associated with systemic sclerosis","volume":"51","author":"O'Reilly","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2007.11.006_bib60","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jdermsci.2006.11.006","article-title":"A cold-response index for the assessment of Raynaud's phenomenon","volume":"45","author":"Foerster","year":"2007","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.rdc.2007.11.006_bib61","first-page":"720","article-title":"Use of thermographic criteria to identify Raynaud's phenomenon in a population setting","volume":"30","author":"Cherkas","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib62","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1053\/mr.2000.4870","article-title":"Thermographic parameters in the diagnosis of secondary Raynaud's phenomenon","volume":"81","author":"Schufried","year":"2000","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.rdc.2007.11.006_bib63","first-page":"1125","article-title":"The \u2018distal-dorsal difference\u2019 as a possible predictor of secondary Raynaud's phenomenon","volume":"26","author":"Clark","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib64","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/rheumatology\/kel330","article-title":"The \u2018distal-dorsal difference\u2019: a thermographic parameter by which to differentiate between primary and secondary Raynaud's phenomenon","volume":"46","author":"Anderson","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2007.11.006_bib65","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1148\/radiographics.22.3.g02ma16583","article-title":"Contrast-enhanced MR angiography of the hand","volume":"22","author":"Connell","year":"2002","journal-title":"Radiographics"},{"key":"10.1016\/j.rdc.2007.11.006_bib66","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/rheumatology\/keh275","article-title":"Laser Doppler imaging: a developing technique for application in the rheumatic diseases","volume":"43","author":"Murray","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2007.11.006_bib67","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0026-2862(03)00018-9","article-title":"Comparison of thermography and laser Doppler imaging in the assessment of Raynaud's phenomenon","volume":"66","author":"Clark","year":"2003","journal-title":"Microvasc Res"},{"key":"10.1016\/j.rdc.2007.11.006_bib68","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0950-821X(05)80123-9","article-title":"Comparison of laser Doppler perfusion imaging, laser Doppler flowmetry, and thermographic imaging for assessment of blood flow in human skin","volume":"8","author":"Seifalian","year":"1994","journal-title":"Eur J Vasc Surg"},{"key":"10.1016\/j.rdc.2007.11.006_bib69","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1006\/mvre.1998.2124","article-title":"Laser Doppler imaging\u2014a new technique for quantifying microcirculatory flow in patients with primary Raynaud's phenomenon and systemic sclerosis","volume":"57","author":"Clark","year":"1999","journal-title":"Microvasc Res"},{"key":"10.1016\/j.rdc.2007.11.006_bib70","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/archinte.166.2.231","article-title":"Phosphodiesterase type 5 inhibition is a novel therapeutic option in Raynaud disease","volume":"166","author":"Caglayan","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.rdc.2007.11.006_bib71","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1002\/art.21911","article-title":"Abnormal microvascular response is localized to the digits in patients with systemic sclerosis","volume":"54","author":"Murray","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2007.11.006_bib72","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0889-857X(03)00019-X","article-title":"Management of Raynaud's phenomenon and digital ischemic lesions in scleroderma","volume":"29","author":"Hummers","year":"2003","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.rdc.2007.11.006_bib73","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1002\/art.10685","article-title":"Cigarette smoking as a significant risk factor for digital vascular disease in patients with systemic sclerosis","volume":"46","author":"Harrison","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2007.11.006_bib74","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/1529-0131(200108)44:8<1841::AID-ART322>3.0.CO;2-8","article-title":"Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis","volume":"44","author":"Thompson","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2007.11.006_bib75","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/0002-9343(85)90402-4","article-title":"Nifedipine in the treatment of Raynaud's phenomenon. Evidence for inhibition of platelet activation","volume":"78","author":"Malamet","year":"1985","journal-title":"Am J Med"},{"key":"10.1016\/j.rdc.2007.11.006_bib76","first-page":"595","article-title":"Acute and sustained effects of dihydropyridine-type calcium channel antagonists on oxidative stress in systemic sclerosis","volume":"116","author":"Allanore","year":"2004","journal-title":"Am J\u00a0Med"},{"key":"10.1016\/j.rdc.2007.11.006_bib77","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/art.1780280504","article-title":"Nifedipine and esophageal dysfunction in progressive systemic sclerosis. A controlled manometric study","volume":"28","author":"Kahan","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2007.11.006_bib78","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/00002281-199811000-00013","article-title":"Rational use of calcium-channel antagonists in Raynaud's phenomenon","volume":"10","author":"Sturgill","year":"1998","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib79","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/01.CIR.94.3.258","article-title":"Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study","volume":"94","author":"Mancini","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.rdc.2007.11.006_bib80","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1053\/hj.1998.v135.86971","article-title":"Vascular remodeling: the role of angiotensin-converting enzyme inhibitors","volume":"135","author":"Chrysant","year":"1998","journal-title":"Am Heart J"},{"key":"10.1016\/j.rdc.2007.11.006_bib81","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1002\/art.22965","article-title":"Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a randomised controlled trial of the ACE-inhibitor quinapril","volume":"56","author":"Gliddon","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2007.11.006_bib82","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1002\/1529-0131(199912)42:12<2646::AID-ANR21>3.0.CO;2-T","article-title":"Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial","volume":"42","author":"Dziadzio","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2007.11.006_bib83","article-title":"Prazosin for Raynaud's phenomenon in progressive systemic sclerosis","volume":"2","author":"Pope","year":"1998","journal-title":"Cochrane Database of Syst Rev"},{"key":"10.1016\/j.rdc.2007.11.006_bib84","doi-asserted-by":"crossref","first-page":"H1075","DOI":"10.1152\/ajpheart.2000.278.4.H1075","article-title":"Silent \u03b1 2c-adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteries","volume":"278","author":"Chotani","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.rdc.2007.11.006_bib85","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1002\/art.20665","article-title":"Efficacy and tolerability of a selective \u03b12C-adrenergic receptor blocker in recovery from cold-induced vasospasm in scleroderma patients. A single-center, double-blind, placebo-controlled, randomized crossover study","volume":"50","author":"Wise","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2007.11.006_bib86","first-page":"321","article-title":"Pulmonary hypertension\u2014beyond vasodilator therapy","volume":"338","author":"Fishman","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2007.11.006_bib87","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1172\/JCI12020","article-title":"Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients","volume":"108","author":"Stratton","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rdc.2007.11.006_bib88","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1080\/00015550152572976","article-title":"Systemic sclerosis-related Raynaud's phenomenon: effects of iloprost infusion therapy on serum cytokine, growth factor and soluble adhesion molecule levels","volume":"81","author":"Mittag","year":"2001","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.rdc.2007.11.006_bib89","article-title":"Iloprost and cisaprost for Raynaud's phenomenon in progressive systemic sclerosis","volume":"2","author":"Pope","year":"1998","journal-title":"Cochrane Database of Syst Rev"},{"key":"10.1016\/j.rdc.2007.11.006_bib90","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/rheumatology\/keg480","article-title":"Safety and efficacy of iloprost for the treatment of ischaemic digits in paediatric connective tissue diseases","volume":"43","author":"Zulian","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2007.11.006_bib91","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/bmj.298.6673.561","article-title":"Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study","volume":"298","author":"Rademaker","year":"1989","journal-title":"Br Med J"},{"key":"10.1016\/j.rdc.2007.11.006_bib92","doi-asserted-by":"crossref","first-page":"199","DOI":"10.7326\/0003-4819-120-3-199402010-00004","article-title":"Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study","volume":"120","author":"Wigley","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2007.11.006_bib93","first-page":"503","article-title":"Effects of long-term cyclic iloprost therapy in systemic sclerosis with Raynaud's phenomenon. A randomized, controlled study","volume":"19","author":"Scorza","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib94","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/rheumatology\/kel038","article-title":"Iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis and the quality of life: a new therapeutic protocol","volume":"45","author":"Milio","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2007.11.006_bib95","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/1529-0131(199804)41:4<670::AID-ART14>3.0.CO;2-I","article-title":"Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multi-center, placebo-controlled, double-blind study","volume":"41","author":"Wigley","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2007.11.006_bib96","first-page":"2173","article-title":"Preventative effect of an oral prostacyclin analog, beraprost sodium, on digital necrosis in systemic sclerosis. French microcirculation society multicentre group for the study of vascular acrosyndromes","volume":"26","author":"Vayssairat","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib97","first-page":"2389","article-title":"Skin blood flow in patients with systemic sclerosis and Raynaud's phenomenon: effects of oral L-arginine supplementation","volume":"26","author":"Khan","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib98","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0140-6736(99)03557-6","article-title":"Acute effect of nitric oxide on Raynaud's phenomenon in scleroderma","volume":"354","author":"Freedman","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2007.11.006_bib99","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/rheumatology\/34.7.636","article-title":"Sustained-release transdermal glyceryl trinitrate patches as a treatment for primary and secondary Raynaud's phenomenon","volume":"34","author":"Teh","year":"1995","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib100","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0140-6736(05)64133-5","article-title":"Skin blood flow after transdermal S-nitrosothio-acetylglucose","volume":"350","author":"Khan","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2007.11.006_bib101","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(99)04095-7","article-title":"Effect of nitric-oxide-generating system on microcirculatory blood flow in skin in patients with severe Raynaud's syndrome: a randomised trial","volume":"354","author":"Tucker","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2007.11.006_bib102","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/rheumatology\/41.3.324","article-title":"Digital vascular response to topical glyceryl trinitrate, as measured by laser Doppler imaging, in primary Raynaud's phenomenon and systemic sclerosis","volume":"41","author":"Anderson","year":"2002","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2007.11.006_bib103","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1136\/ard.2003.015677","article-title":"Severe digital ischaemia treated with phosphodiesterase inhibitors","volume":"63","author":"Kumana","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2007.11.006_bib104","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1161\/CIRCULATIONAHA.104.523324","article-title":"Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy","volume":"112","author":"Fries","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.rdc.2007.11.006_bib105","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1136\/ard.2004.034488","article-title":"Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis","volume":"64","author":"Gore","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2007.11.006_bib106","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/sj.clpt.6100103","article-title":"The effects of tadalafil on cold-induced vasoconstriction in patients with Raynaud's phenomenon","volume":"81","author":"Friedman","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.rdc.2007.11.006_bib107","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.amjcard.2003.08.013","article-title":"Effects of cilostazol in patients with Raynaud's syndrome","volume":"92","author":"Rajagopalan","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.rdc.2007.11.006_bib108","first-page":"312","article-title":"Endothelin-1 and endothelin receptor antagonists in cardiovascular remodeling","volume":"221","author":"Kirchengast","year":"1999","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.rdc.2007.11.006_bib109","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/art.10895","article-title":"Endothelin and endothelin receptor antagonists in systemic rheumatic disease","volume":"48","author":"Mayes","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2007.11.006_bib110","first-page":"1268","article-title":"Localization of endothelin-1 and its binding sites in scleroderma skin","volume":"21","author":"Vancheeswaran","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib111","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/art.20676","article-title":"Digital ulcers in systemic sclerosis. Prevention by treatment with bosentan, an oral endothelin receptor antagonist","volume":"50","author":"Korn","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"Suppl II","key":"10.1016\/j.rdc.2007.11.006_bib112","first-page":"90","article-title":"Bosentan reduces the number of new\u00a0digital ulcers in patients with systemic sclerosis","volume":"65","author":"Seibold","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2007.11.006_bib113","article-title":"Ketanserin for Raynaud's phenomenon in progressive systemic sclerosis","volume":"2","author":"Pope","year":"1998","journal-title":"Cochrane Database of Syst Rev"},{"key":"10.1016\/j.rdc.2007.11.006_bib114","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/rheumatology\/40.9.1038","article-title":"Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine","volume":"40","author":"Coleiro","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2007.11.006_bib115","first-page":"4","article-title":"The emerging problem of oxidative stress and the role of antioxidants in systemic sclerosis","volume":"19","author":"Herrick","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib116","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/rheumatology\/38.4.309","article-title":"Probucol improves symptoms and reduces lipoprotein oxidation susceptibility in patients with Raynaud's phenomenon","volume":"38","author":"Denton","year":"1999","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2007.11.006_bib117","first-page":"349","article-title":"A double-blind placebo-controlled trial of antioxidant therapy in limited cutaneous systemic sclerosis","volume":"18","author":"Herrick","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib118","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.freeradbiomed.2004.09.032","article-title":"Effects of short-term treatment with vitamin E in systemic sclerosis: a double-blind, randomized, controlled clinical trial of efficacy based on urinary isoprostane measurement","volume":"38","author":"Cracowski","year":"2005","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.rdc.2007.11.006_bib119","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/art.1780271009","article-title":"Trial of platelet-inhibiting drug in scleroderma","volume":"27","author":"Beckett","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2007.11.006_bib120","first-page":"499","article-title":"Long-term low molecular weight heparin therapy for severe Raynaud's phenomenon: a pilot study","volume":"18","author":"Denton","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib121","first-page":"260","article-title":"Treatment of severe Raynaud's phenomenon and ischemic ulcerations with tissue plasminogen activator","volume":"17","author":"Lakshminarayanan","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib122","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/01.prs.0000244860.00674.57","article-title":"Management of vasospastic disorders with botulinum toxin A","volume":"119","author":"Van Beek","year":"2007","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.rdc.2007.11.006_bib123","first-page":"269","article-title":"Adventitial stripping: a digit saving procedure in refractory Raynaud's phenomenon","volume":"25","author":"Yee","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib124","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1053\/jhsu.1999.jhsu24a0173","article-title":"The use of digital artery sympathectomy as a salvage procedure for severe ischemia of Raynaud's disease and phenomenon","volume":"24","author":"McCall","year":"1999","journal-title":"J Hand Surg [Am]"},{"key":"10.1016\/j.rdc.2007.11.006_bib125","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/micr.1013","article-title":"Surgery for ischemic pain and Raynaud's phenomenon in scleroderma: a description of treatment protocol and evaluation of results","volume":"21","author":"Tomaino","year":"2001","journal-title":"Microsurgery"},{"key":"10.1016\/j.rdc.2007.11.006_bib126","first-page":"1788","article-title":"A systematic review of the outcomes of digital sympathectomy for treatment of chronic digital ischemia","volume":"30","author":"Kotsis","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib127","first-page":"642","article-title":"Surgery of the hand in patients with systemic sclerosis: outcomes and considerations","volume":"32","author":"Bogoch","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.006_bib128","first-page":"39","article-title":"Improvement of acral circulation in a patient with systemic sclerosis with stellate blocks","volume":"27","author":"Klyscz","year":"1998","journal-title":"Vasa"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X07000981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X07000981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:08:57Z","timestamp":1760180937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X07000981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":128,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0889857X07000981"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2007.11.006","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and Management of Scleroderma Peripheral Vascular Disease","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2007.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}